First-Line Treatment of Primary Erythema Nodosum
Primary erythema nodosum presents as erythematous nodules, typically on the pretibial area. The condition is generally self-limited, with most cases resolving within 1–6 weeks with appropriate symptomatic management.
Treatment Goals
The primary clinical aims are resolution of erythematous nodules on the pretibial area within 1–6 weeks, together with relief of pain and edema in the lower extremities.
First-Line Approach
Symptomatic and supportive care is adequate for most patients. The first-line approach includes physical measures directed at lower-limb edema and discomfort, alongside an oral anti-inflammatory agent for pain control.
The complete regimen — specific agents, sequencing, and monitoring guidance — is available in the full structured protocol below.
References
DOI: 10.1007/s40257-021-00592-w
- Symptomatic support is an adequate approach for most patients.
- Compression bandages and limb elevation may be used for edema and pain relief.
- Non-steroidal anti-inflammatory drugs, such as indomethacin at 100–150 mg/day or naproxen 500 mg/day, may be used for pain control.
- Erythema nodosum is generally self-limited and resolves within 1–6 weeks by turning from a bright red to a yellow–brown or green-bluish discoloration, resembling bruises.